| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/11/2002 | CA2434136A1 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | CA2434118A1 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | CA2433800A1 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | CA2433749A1 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 07/11/2002 | CA2433552A1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | CA2433041A1 Use of intermediate-conductance potassium channels and modulators for diagnosing and treating diseases involving disturbed keratinocyte activiyty |
| 07/11/2002 | CA2432902A1 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression |
| 07/10/2002 | EP1221490A2 Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars |
| 07/10/2002 | EP1221483A1 NF-AT polypeptides and polynucleotides |
| 07/10/2002 | EP1221480A1 Polypeptide humanin inhibiting nerve cell death |
| 07/10/2002 | EP1221477A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/10/2002 | EP1220948A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220942A1 41 human secreted proteins |
| 07/10/2002 | EP1220938A1 Materials and methods for simplified aav production |
| 07/10/2002 | EP1220932A1 Human carboxypeptidases and polynucleotides encoding the same |
| 07/10/2002 | EP1220931A1 Dna encoding prost 07 polypeptide |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220925A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 07/10/2002 | EP1220922A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 07/10/2002 | EP1220921A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 07/10/2002 | EP1220920A1 The prv-1 gene and use thereof |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220917A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 07/10/2002 | EP1220914A1 Human g-protein coupled receptor |
| 07/10/2002 | EP1220913A1 G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
| 07/10/2002 | EP1220911A2 P-glycoproteins and uses thereof |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220903A1 Gene selection using pnas |
| 07/10/2002 | EP1220901A1 26 human secreted proteins |
| 07/10/2002 | EP1220900A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 07/10/2002 | EP1220897A1 Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease |
| 07/10/2002 | EP1220896A1 Novel human lipase proteins, nucleic acids encoding them, and uses of both of these |
| 07/10/2002 | EP1220895A1 Novel gene encoding a dna methyltransferase, dnmt3l |
| 07/10/2002 | EP1220866A1 Antisense modulation of bcl-6 expression |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220681A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 07/10/2002 | EP1220679A1 Cell-based gene therapy for the pulmonary system |
| 07/10/2002 | CN1358228A Polynucleotide and deduced amino acid sequences from stromal cells |
| 07/10/2002 | CN1087344C Transforming growth factor alpha-H1 |
| 07/10/2002 | CN1087293C New amino alcohol derivatives, process for production thereof and medicaments and reagents containing these compounds |
| 07/09/2002 | US6417169 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growth |
| 07/09/2002 | US6417168 Anticancer treatment with killing cells |
| 07/09/2002 | US6416998 Polypeptides |
| 07/09/2002 | US6416997 Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery |
| 07/09/2002 | US6416984 Human DNA mismatch repair proteins |
| 07/09/2002 | US6416976 TrpS |
| 07/09/2002 | US6416975 Human glycine transporter type 2 |
| 07/09/2002 | US6416956 Screening for and/or diagnosing breast cancer by obtaining cell sample from patient and determining whether bp1 is overexpressed by said cell sample as compared to normal cells |
| 07/09/2002 | US6416947 Vaccine adjuvant and vaccine method |
| 07/09/2002 | US6416754 Anaerobe targeted enzyme-mediated prodrug therapy |
| 07/04/2002 | WO2002052274A2 Screening method based on tsap6 binding partners |
| 07/04/2002 | WO2002052020A2 Regulation of human carboxypeptidase a |
| 07/04/2002 | WO2002052016A2 Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme |
| 07/04/2002 | WO2002052009A1 Human fgf23 protein mutant lowering blood phosphorus level |
| 07/04/2002 | WO2002052004A1 Gene involved in apoptosis regulation |
| 07/04/2002 | WO2002052001A1 Method of identifying dna encoding physiologically active polypeptide in mammalian body |
| 07/04/2002 | WO2002051994A2 Polypeptides |
| 07/04/2002 | WO2002051981A2 Defects in periaxin associated with myelinopathies |
| 07/04/2002 | WO2002051980A2 In vitro-derived adult pluripotent stem cells and uses therefor |
| 07/04/2002 | WO2002051978A2 Yeasts transformed by genes enhancing their cold stress tolerance |
| 07/04/2002 | WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2002051858A2 Antisense modulation of chk2 expression |
| 07/04/2002 | WO2002051438A2 Use of repulsive guidance molecule (rgm) and its modulators |
| 07/04/2002 | WO2002051430A2 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | WO2002033100A3 Regulation of human adenylate cyclase, type iv |
| 07/04/2002 | WO2002030351A3 Improvement of graft acceptance through manipulation of thymic regeneration |
| 07/04/2002 | WO2002017968A9 Sensitization of cancer cells to immunoconjugate-induced cell death by transfection with il-13 receptor alpha chain-2 |
| 07/04/2002 | WO2002004953A8 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 07/04/2002 | WO2002000870A3 Method for transfecting cells using a magnetic field |
| 07/04/2002 | WO2001096532A3 Method of generating pluripotent mammalian cells by fusion of a cytoplast fragment with a karyoplast |
| 07/04/2002 | WO2001094400A3 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| 07/04/2002 | WO2001085974A3 Retroviral vectors comprising an enhanced 3' transcription termination structure |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001070979A3 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 07/04/2002 | WO2001068855A3 Gtp-binding protein gamma-12 subunit |
| 07/04/2002 | WO2001055364A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055328A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055325A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055322A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055321A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055318A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055311A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001055308A3 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | WO2001036589A9 Human ex vivo immune system |
| 07/04/2002 | WO2001025441A3 Tumour-specific vector for gene therapy |
| 07/04/2002 | WO2000074687A9 Antisense modulation of b7 protein expression |
| 07/04/2002 | WO2000069897A9 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes |
| 07/04/2002 | WO2000022430A9 Neisseria genomic sequences and methods of their use |
| 07/04/2002 | US20020088019 Methods of and pharmaceutical compositions for improving implantation of embryos |
| 07/04/2002 | US20020088014 Minimal adenovirus mediated recombinant vaccine |
| 07/04/2002 | US20020086987 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 07/04/2002 | US20020086975 P2u2 receptor antibodies |
| 07/04/2002 | US20020086849 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 07/04/2002 | US20020086848 Associated with Fanconi anaemia (FA), a genetic disease; antibodies, gene therapy |
| 07/04/2002 | US20020086847 DNA encoding a recombinant antibody molecule end-specific for an amyloid-beta peptide for preventing or inhibiting progression of Alzheimer's Disease |
| 07/04/2002 | US20020086846 Gene transfer to renal glomerular cells |
| 07/04/2002 | US20020086845 Rat PTTG polypeptide and method for producing it |